About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Ohio | 525 Studies

Clinical Trials Prostate CancerOhio

Prostate Cancer Clinical Trials in Ohio

Find 525 clinical trials for prostate cancer near Ohio. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 501-520 of 525 trials

CompletedStudy of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsThis is a Phase Ib/II, multicenter, open-label study to evaluate the safety and preliminary efficacy of TT-00420 tablet, as monotherapy or in combination regimens, in patients…NCT04742959·Duarte, California and 5 others RecruitingComprehensive Outcomes for After Cancer HealthThis study intends to explore feasibility, acceptability, and outcomes related to the use of a digital health coaching intervention for individuals who have completed primary…NCT05349227·Gainesville, Florida and 6 others RecruitingStudy of DCC-2812 in Participants With Advanced Genitourinary CancersThis is a multicenter clinical trial to evaluate the safety and preliminary activity of the selective general control nonderepressible 2 (GCN2) activator DCC-2812 as monotherapy…NCT06966024·Boston, Massachusetts and 7 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingCleveland African American Prostate Cancer ProjectThe purpose of this research is to test intervention strategies that encourage and support Black or African American men who are 40 and older to complete prostate cancer…NCT05469269·Cleveland, Ohio

RecruitingA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasThe purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of…NCT04104776·Tampa, Florida and 79 others

RecruitingMetastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TA multicenter, open-label, prospective study to investigate immune boost response changes in patients with metastatic castrate-resistant prostate cancer (mCRPC).NCT06134232·Tuscon, Arizona and 30 others

CompletedSamarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate CancerRATIONALE: Giving samarium Sm 153 lexidronam pentasodium and 3-dimensional (3-D) conformal radiation therapy or intensity-modulated radiation therapy may keep prostate cancer from…NCT00551525·Phoenix, Arizona and 28 others

CompletedA Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate CancerThis study will evaluate the response rate of MLN8237 in patients with histologically confirmed or clinically suspected metastatic neuroendocrine prostate cancer (NEPC).NCT01799278·Chicago, Illinois and 7 others

CompletedRadiation Therapy With Androgen Suppression in Treating Patients With Prostate CancerRATIONALE: Imaging procedures such as MRI may improve the ability to determine the response of prostate tumors to therapy.NCT00002889·San Francisco, California and 11 others

RecruitingPhase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsThis is a first-in-human, open-label, multicenter phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of…NCT06784193·Gilbert, Arizona and 24 others

Active not recruitingProstate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C)Reduction of dose to or 'sparing' of neurovascular structures during stereotactic ablative body radiotherapy (SAbR) for localized prostate cancer will improve retention of sexual…NCT03525262·San Francisco, California and 7 others

CompletedSoy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen LevelsRATIONALE: Soy protein supplement may prevent or delay the development of prostate cancer in patients who have elevated prostate-specific antigen (PSA) levels.NCT00031746·Washington D.C., District of Columbia and 4 others

CompletedSafety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate CancerThe purpose of this study is to evaluate safety, tolerability and pharmacokinetics of ODM-201 in patients with castrate resistant prostate cancer.NCT01317641·Wheat Ridge, Colorado and 22 others

CompletedStudy of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate CancerThe purpose of this trial is to confirm a safe dose of AS1404, to be given with docetaxel, and to see whether adding AS1404 and docetaxel together improves the outcome of the…NCT00111618·Alhambra, California and 26 others

RecruitingFK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate CancerThe goal of this clinical trial is to learn if the vaccine FK-PC101 works to delay or prevent the return of prostate cancer in men who have had surgery to remove their prostate…NCT06636682·Chicago, Illinois and 2 others

Active not recruitingClinical Investigation of the da Vinci Surgical SystemThis prospective, multicenter, single-arm study is being conducted to confirm safety, effectiveness, and usability of da Vinci Surgical System in performing robotic-assisted…NCT05682742·Orlando, Florida and 3 others

CompletedSoy Isoflavones in Treating Patients With Recurrent Prostate Cancer or Rising Prostate-Specific AntigenRATIONALE: Eating a diet high in soy foods may lower the risk of some types of cancer. Isoflavones are compounds found in soy food that may prevent cancer.NCT01682941·Columbus, Ohio

CompletedStudy of INKmune in Patients With mCRPC (CaRe Prostate)This is an open-label, phase I/IIa dose escalation and expansion study of INKmune in men with mCRPC.NCT06056791·Los Angeles, California and 7 others

RecruitingDocetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseThis study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs?NCT06592924·Anchorage, Alaska and 394 others

UnknownA Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid TumorsThe purpose of this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of JBI-802 in patients with Advanced Solid Tumors.The efficacy of…NCT05268666·Denver, Colorado and 3 others

PreviousPage 26 of 27Next

Other Conditions in Ohio

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma